Jagsonpal Pharmaceuticals Limited
NSE:JAGSNPHARM.NS
Overview | Financials
Company Name | Jagsonpal Pharmaceuticals Limited |
Symbol | JAGSNPHARM.NS |
Currency | INR |
Price | 714.1 |
Market Cap | 18,934,290,090 |
Dividend Yield | 1.51% |
52-week-range | 273.6 - 820.1 |
Industry | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Manish Gupta |
Website | https://www.jagsonpal.com |
An error occurred while fetching data.
About Jagsonpal Pharmaceuticals Limited
Jagsonpal Pharmaceuticals Limited develops and manufactures bulk drugs and pharmaceutical formulations in the areas of women health, pain and analgesics, and general medicine. It offers general medicines, such as allergy management, immunity and cell protection, gut and mind management, anti-infectives, and dentist and ENT range products; and women's healthcare products,
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD